Glucagon

Jun 18, 2020

Innovent Announces First Patient Dosed in A Phase 1b/2 Clinical Trial of IBI362, a Dual GLP-1 and Glucagon Receptor Agonist, in China

Apr 23, 2020

U.S. FDA grants orphan drug designation to AmideBio's glucagon analog for the treatment of congenital hyperinsulinism

Feb 14, 2020

JDRF Reaches New Milestones in Work to Drive Cures for Type 1 Diabetes and Improve Lives

Nov 19, 2019

Kadimastem Announces Successful Preclinical Results of Its Cell Therapy Treatment for Insulin-dependent Diabetes

Aug 21, 2019

Innovent Enters a Licensing Agreement with Lilly to Develop & Commercialize a Novel Diabetes Medicine in China

Jul 24, 2019

BAQSIMI(TM) (glucagon) Nasal Powder 3 mg, the First and Only Nasally Administered Glucagon to Treat Severe Hypoglycemia in Adults and Children with Diabetes Ages Four Years and Older, Approved by FDA

Jun 19, 2019

SERAXIS Inc. inks Research Collaborative Agreement with North Carolina Research Hospital

Jun 18, 2019

Oramed Provides Clinical Update with Meaningful Data Expected by Year-End

Mar 01, 2018

Injection Pen Market to Grow at 6.0% CAGR to 2022

Jan 03, 2018

Glucagon Receptor Structure Offers New Opportunities for Type 2 Diabetes Drug Discovery